BNC2 is a nuclear zinc-finger transcription factor with prominent roles in skin and urogenital development. It functions as a keratinocyte-specific transcription factor and regulates skin pigmentation through allele-dependent enhancer activity; genetic variants in BNC2 are associated with variation in skin color saturation and hue in Europeans 12. BNC2 is also essential for distal urethral development, with disruptions causing urethral defects 3. Beyond development, BNC2 functions as a myofibroblast identity transcription factor required for fibrotic responses. It integrates pro-fibrotic signals including TGFβ and Hippo/YAP1 signaling to induce collagen expression 45. Post-translational modification by O-GlcNAcylation stabilizes BNC2 and its interaction with TEAD4 and YAP1, controlling myofibroblastic activation 5. In cancer, BNC2 functions as a putative tumor suppressor. In high-grade serous ovarian carcinoma, reduced BNC2 expression confers resistance to oxidative stress and promotes oncogenic transformation 6. Circular RNA derived from BNC2 suppresses oral squamous cell carcinoma and prostate cancer progression through microRNA sponging mechanisms 78. Clinically, BNC2 represents a druggable target; the thalidomide derivative CC-885 inhibits BNC2 function and blocks myofibroblastic activation in fibrosis models 4.